New Information on Drug Resistance: Implications for the Adjuvant Treatment of Breast Cancer-Reference-Cited by-同舟云学术

New Information on Drug Resistance: Implications for the Adjuvant Treatment of Breast Cancer

Published:1989 Issue: Volume: Page:8-16
ISSN:0080-0015
Container-title:Adjuvant Therapy of Primary Breast Cancer
language:
Short-container-title:

Author:

Goldie J. H.

Publisher

Springer Berlin Heidelberg

Link

http://link.springer.com/content/pdf/10.1007/978-3-642-83337-3_2.pdf

Reference22 articles.

1. Bonadonna G, Valagussa P (1985) Adjuvant systemic therapy for resectable breast cancer. J Clin Oncol 3: 259–275

2. Bonadonna G, Valagussa P (1987) Current status of adjuvant chemotherapy for breast cancer. Semin Oncol 14: 8–22

3. Bruce WR, Meeker BE, Veleriote FA (1966) Comparison of the sensitivity of normal hematopoietic and transplanted lymphoma colony forming cells to chemotherapeutic agents administered in vivo. J Natl Cancer Inst 37: 233–242

4. Buzdar A, Smith T, Blumenschein G et al. (1981) Adjuvant chemotherapy with fluorouracil, doxorubicin and cyclophosphamide (FAC) for stage II or stage III breast cancer: five year results, In: Salmon SE, Jones SE (eds) Adjuvant therapy of cancer III. Grune and Stratton Orlando, Florida pp 419–426

5. Coldman AJ, Goldie JH (1983) A model for the resistance of tumour cells to cancer chemotherapeutic agents. Mathematical Biosciences 65: 291–307

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Trastuzumab and Liposomal Doxorubicin in the Treatment of MCF-7 Xenograft Tumor-Bearing Mice: Combination Does Not Affect Drug Serum Levels;Pharmaceutical Research;2005-06

2. Retreating recurrent breast cancer with the same CMF-containing regimen used as adjuvant therapy;European Journal of Cancer;1997-12

3. Mechanisms of Treatment Failure;Adjuvant Therapy of Breast Cancer IV;1993

4. Sequential cytopunctures during preoperative chemotherapy for primary breast carcinoma. II. DNA flow cytometry changes during chemotherapy, tumor regression, and short-term follow-up;Cancer;1992-01-15